ITRM20040168A1 - Composizione a rilascio modificato ph dipendente. - Google Patents

Composizione a rilascio modificato ph dipendente.

Info

Publication number
ITRM20040168A1
ITRM20040168A1 IT000168A ITRM20040168A ITRM20040168A1 IT RM20040168 A1 ITRM20040168 A1 IT RM20040168A1 IT 000168 A IT000168 A IT 000168A IT RM20040168 A ITRM20040168 A IT RM20040168A IT RM20040168 A1 ITRM20040168 A1 IT RM20040168A1
Authority
IT
Italy
Prior art keywords
modified release
employee
release composition
active ingredients
matrices
Prior art date
Application number
IT000168A
Other languages
English (en)
Inventor
Gaetano Giammona
Delia Mandracchia
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Priority to IT000168A priority Critical patent/ITRM20040168A1/it
Publication of ITRM20040168A1 publication Critical patent/ITRM20040168A1/it
Priority to SI200530711T priority patent/SI1729732T1/sl
Priority to JP2007505744A priority patent/JP2007530666A/ja
Priority to US10/596,267 priority patent/US20070166383A1/en
Priority to CN2005800036356A priority patent/CN1913875B/zh
Priority to AU2005228716A priority patent/AU2005228716B2/en
Priority to AT05718991T priority patent/ATE428405T1/de
Priority to DK05718991T priority patent/DK1729732T3/da
Priority to HR20090329T priority patent/HRP20090329T1/xx
Priority to PL05718991T priority patent/PL1729732T3/pl
Priority to KR1020067016168A priority patent/KR20060133578A/ko
Priority to PT05718991T priority patent/PT1729732E/pt
Priority to DE602005013935T priority patent/DE602005013935D1/de
Priority to ES05718991T priority patent/ES2325626T3/es
Priority to CA002551797A priority patent/CA2551797A1/en
Priority to PCT/IT2005/000081 priority patent/WO2005094792A1/en
Priority to RSP-2009/0315A priority patent/RS51178B/sr
Priority to EP05718991A priority patent/EP1729732B1/en
Priority to BRPI0509475-5A priority patent/BRPI0509475A/pt
Priority to CY20091100701T priority patent/CY1109209T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IT000168A 2004-04-01 2004-04-01 Composizione a rilascio modificato ph dipendente. ITRM20040168A1 (it)

Priority Applications (20)

Application Number Priority Date Filing Date Title
IT000168A ITRM20040168A1 (it) 2004-04-01 2004-04-01 Composizione a rilascio modificato ph dipendente.
BRPI0509475-5A BRPI0509475A (pt) 2004-04-01 2005-02-16 matrizes de hidrogel aniÈnico com liberação modificada dependente do ph como veìculos de fármacos
HR20090329T HRP20090329T1 (hr) 2004-04-01 2005-02-16 Matrica anionskog hidrogela s ph ovisnim modificiranim oslobađanjem kao nosač lijeka
KR1020067016168A KR20060133578A (ko) 2004-04-01 2005-02-16 약물 담체로서 피에이치 의존성의 개질된 방출을 갖는음이온성 하이드로젤 기질
US10/596,267 US20070166383A1 (en) 2004-04-01 2005-02-16 Anionic hydrogel matrices with ph dependent modified release as drug carriers
CN2005800036356A CN1913875B (zh) 2004-04-01 2005-02-16 作为药物载体的具有pH依赖性调节释放性质的阴离子水凝胶基质
AU2005228716A AU2005228716B2 (en) 2004-04-01 2005-02-16 Anionic hydrogel matrices with pH dependent modified release as drug carriers
AT05718991T ATE428405T1 (de) 2004-04-01 2005-02-16 Anionische hydrogelmatrizes mit ph-abhängiger modifizerter wirkstofffreisetzung als arzneimittelträger
DK05718991T DK1729732T3 (da) 2004-04-01 2005-02-16 Anioniske hydrogelmatricer med pH-afhængig frigivelse som lægemiddelbærere
SI200530711T SI1729732T1 (sl) 2004-04-01 2005-02-16 Matriksi iz anionskega hidrogela z modificiranim sproĺ äśanjem, odvisnim od ph, kot nosilci za zdravila
PL05718991T PL1729732T3 (pl) 2004-04-01 2005-02-16 Anionowe matryce hydrożelowe o zależnym od pH modyfikowanym uwalnianiu jako nośniki leków
JP2007505744A JP2007530666A (ja) 2004-04-01 2005-02-16 薬物担体としてｐＨ依存的調節放出を伴うアニオン性ヒドロゲルマトリックス
PT05718991T PT1729732E (pt) 2004-04-01 2005-02-16 Matrizes de hidrogeles aniónicos de libertação modificada dependente do ph como veículos de fármacos
DE602005013935T DE602005013935D1 (de) 2004-04-01 2005-02-16 Anionische hydrogelmatrizes mit ph-abhängiger modifizerter wirkstofffreisetzung als arzneimittelträger
ES05718991T ES2325626T3 (es) 2004-04-01 2005-02-16 Matrices de hidrogel anionico con liberacion modificada dependiente del ph como vehiculos farmacologicos.
CA002551797A CA2551797A1 (en) 2004-04-01 2005-02-16 Anionic hydrogel matrices with ph dependent modified release as drug carriers
PCT/IT2005/000081 WO2005094792A1 (en) 2004-04-01 2005-02-16 Anionic hydrogel matrices with ph dependent modified release as drug carriers
RSP-2009/0315A RS51178B (sr) 2004-04-01 2005-02-16 Anjonski hidrogelni matriksi sa ph zavisnim modifikovanim oslobađanjem kao nosači lekova
EP05718991A EP1729732B1 (en) 2004-04-01 2005-02-16 Anionic hydrogel matrices with ph dependent modified release as drug carriers
CY20091100701T CY1109209T1 (el) 2004-04-01 2009-07-03 Μητρες ανιονικης υδρογελης με ph-εξαρτωμενη τροποιημενη αποδεσμευση ως μεταφορεις φαρμακων

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000168A ITRM20040168A1 (it) 2004-04-01 2004-04-01 Composizione a rilascio modificato ph dipendente.

Publications (1)

Publication Number Publication Date
ITRM20040168A1 true ITRM20040168A1 (it) 2004-07-01

Family

ID=34961555

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000168A ITRM20040168A1 (it) 2004-04-01 2004-04-01 Composizione a rilascio modificato ph dipendente.

Country Status (20)

Country Link
US (1) US20070166383A1 (it)
EP (1) EP1729732B1 (it)
JP (1) JP2007530666A (it)
KR (1) KR20060133578A (it)
CN (1) CN1913875B (it)
AT (1) ATE428405T1 (it)
AU (1) AU2005228716B2 (it)
BR (1) BRPI0509475A (it)
CA (1) CA2551797A1 (it)
CY (1) CY1109209T1 (it)
DE (1) DE602005013935D1 (it)
DK (1) DK1729732T3 (it)
ES (1) ES2325626T3 (it)
HR (1) HRP20090329T1 (it)
IT (1) ITRM20040168A1 (it)
PL (1) PL1729732T3 (it)
PT (1) PT1729732E (it)
RS (1) RS51178B (it)
SI (1) SI1729732T1 (it)
WO (1) WO2005094792A1 (it)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4746883B2 (ja) * 2005-01-28 2011-08-10 リンテック株式会社 ハイドロゲル基剤、パップ剤基剤、パップ剤及び水性ゲルシート
JP5833450B2 (ja) 2008-12-31 2015-12-16 スリーエム イノベイティブ プロパティズ カンパニー 微小粒子を用いた生きた生物負荷の検出法
BRPI0918693A2 (pt) 2008-12-31 2016-07-26 3M Innovative Properties Co dispositivos para amostragem e métodos para concentração de microorganismos
CN102770208B (zh) 2009-12-30 2016-02-03 3M创新有限公司 使用微粒进行的活生物负载检测
WO2011082258A2 (en) 2009-12-30 2011-07-07 Regents Of The University Of Minnesota Bone cement and method
WO2011090349A2 (ko) * 2010-01-21 2011-07-28 광주과학기술원 피부투과도, 세포유입 및 종양전달성이 증가된 나노운반체
KR101228106B1 (ko) * 2010-01-21 2013-02-01 광주과학기술원 피부투과도, 세포유입 및 종양전달성이 증가된 나노운반체
CN103330702B (zh) * 2013-07-02 2016-03-02 江苏长泰药业有限公司 含有拟交感神经胺盐和诱导凝胶体系的医药组合物
CN108452291A (zh) * 2018-07-04 2018-08-28 西南大学 用天然丝胶蛋白治疗溃疡性结肠炎的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4071508A (en) * 1975-02-11 1978-01-31 Plastomedical Sciences, Inc. Anionic hydrogels based on hydroxyalkyl acrylates and methacrylates
IT1284661B1 (it) * 1996-06-06 1998-05-21 Sigma Tau Ind Farmaceuti Uso di alcanoil l-carnitine nel trattamento terapeutico di malattie infiammatorie croniche intestinali.
DE19653631A1 (de) * 1996-12-20 1998-06-25 Basf Coatings Ag Verfahren zum Herstellen von durch Strahlung vernetzbaren polymeren Acryl- oder Methacrylsäureestern
AU736784B2 (en) * 1997-06-03 2001-08-02 Celltran Limited New medicaments based on polymers composed of methacrylamide-modified gelatin
BR0007974A (pt) * 1999-02-03 2001-10-30 Powderject Res Ltd Usos de um agente farmacologicamente ativo, deum constructo de gene e de um antìgeno, métodospara produzir uma composição farmacêutica em póe para administrar uma droga a um indivìduo emnecessidade dela, composição farmacêutica, formade dosagem unitária, e, artigo de manufatura parasuprimento transdérmico ou transmucoso de umagente farmacologicamente ativo a um indivìduo
US6547182B2 (en) * 2001-07-19 2003-04-15 Aerojet-General Corporation Solid rocket motor bolted thrust takeout structure
US7204997B2 (en) * 2002-01-29 2007-04-17 Supratek Pharma Inc. Responsive microgel and methods related thereto

Also Published As

Publication number Publication date
BRPI0509475A (pt) 2007-09-11
CY1109209T1 (el) 2014-07-02
RS51178B (sr) 2010-10-31
EP1729732A1 (en) 2006-12-13
HRP20090329T1 (hr) 2009-09-30
SI1729732T1 (sl) 2009-08-31
JP2007530666A (ja) 2007-11-01
ATE428405T1 (de) 2009-05-15
PT1729732E (pt) 2009-07-02
ES2325626T3 (es) 2009-09-10
WO2005094792A1 (en) 2005-10-13
AU2005228716B2 (en) 2010-07-15
CN1913875A (zh) 2007-02-14
DE602005013935D1 (de) 2009-05-28
PL1729732T3 (pl) 2009-09-30
US20070166383A1 (en) 2007-07-19
DK1729732T3 (da) 2009-08-10
AU2005228716A1 (en) 2005-10-13
CN1913875B (zh) 2011-08-31
EP1729732B1 (en) 2009-04-15
KR20060133578A (ko) 2006-12-26
CA2551797A1 (en) 2005-10-13

Similar Documents

Publication Publication Date Title
BRPI0511478A (pt) composições de vidro como aditivo antimicrobiano para materiais dentários
DOP2006000179A (es) 7-aza-indazoles sustituidos, composiciones que les contienen, procedimiento de fabricación y utilización
CY1109209T1 (el) Μητρες ανιονικης υδρογελης με ph-εξαρτωμενη τροποιημενη αποδεσμευση ως μεταφορεις φαρμακων
CR11167A (es) Uso de homo y copolimeros para la estabilizacion de formulaciones de principios activos
AR102999A2 (es) Combinaciones sinérgicas de compuestos activos fungicidas, usos y métodos
UA100851C2 (ru) Средство для борьбы с паразитами на животных
MXPA05007328A (es) Composiciones que contienen agentes antiacne y el uso de las mismas.
CY1109916T1 (el) Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις
HRP20070374T3 (en) Formulations comprising ecteinascidin and a disaccharide
CR9750A (es) Dispersiones solidas amorfas de 7-cloro-n,n,5-trimetil-4-oxo-3-fenil-3,5-dihidro-4h-prirdazino[4,5-b]indol-1-acetamida
CL2007002887A1 (es) Compuestos derivados de heterociclos, inhibidores de metaloproteinasa de la matriz (mmp); compuesto intermediario; composicion farmaceutica; kit farmaceutico; y uso en la prevencion y tratamiento en afecciones mediadas por metaloproteinasas de la mat
GT200600520A (es) Agentes antibacterianos
AR054937A1 (es) Goma de mascar biodegradable
EP1969940A3 (en) Nematicidal compositions
UY28987A1 (es) Cuerpos de moldeo solidos que contienen sustancia activa para el uso externo frente a parasitos en animales
UY29236A1 (es) 2-alcoxi-3,4,5-trihidroxi-alquilamidas. su preparación, composiciones que las contienen y su utilización.
BRPI0414114A (pt) uso de defibrotide, formulação, e, método para tratar um mamìfero afetado por um tumor
NO20074528L (no) Substituerte pyrroler, sammensetninger, fremgangsmate for fremstilling og anvendelse av samme
FR2894143B1 (fr) Composition a liberation prolongee de l'actif, son procede de preparation et son utilisation.
MX2007013327A (es) Formulaciones de liberacion prolongada.
TW200700085A (en) Endoparasiticidal compositions
DE60041198D1 (de) Antimikrobielle zusammensetzungen
TNSN07438A1 (en) Prolonged release formulation of active principles having a ph-dependent solubility
WO2005002570A8 (en) Use of an aziridino compound to selectively inactivate parasites in biological compositions
ES2421520T3 (es) Potenciador de la producción de adiponectina